In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomes.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
Works matching IS 10568751 AND DT 2014 AND VI 160 AND IP 6
Results: 12
1
2
Warfarin dosing by genotype did not improve time in therapeutic range.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
3
Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
4
In overweight or obese patients with atrial fibrillation, a weight reduction program reduced symptoms.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
5
Review: In relapsing–remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
6
In suspected ACS, a diagnostic protocol using hs-TnI identified patients at low cardiac risk at 30 days.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
7
Review: Some clinical tests performed by specialists identify rotator cuff disease or tears.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
8
Individual chest pain characteristics had low accuracy for detecting acute MI in both men and women.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
9
In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic range.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
10
In intracranial artery stenosis, adding angioplasty and stenting to medical therapy increased stroke or death.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
11
Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
12
Review: Adding α1-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article